ClinicalTrials.gg
RecruitingNCT07752693REBOZOUpdated Nov 5, 2026

The Effect Of Partner-Assısted Rebozo Technıque On Labor Paın And Satısfactıon In Prımary Pregnant Women

An interventional study of Rebozo Technique in Labor Pains, sponsored by Istanbul Saglik Bilimleri University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Istanbul Saglik Bilimleri University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years to 49 Years
Sex
Female
01

Study summary

The main objective of this study is to examine the effect of the rebozo technique, applied with partner support, on labor pain and birth satisfaction in primiparous pregnant women. This research is planned as a randomized controlled experimental study. A total of 64 pregnant women, 32 in the control group and 32 in the experimental group, who meet the sample selection criteria and agree to participate in the study, will constitute the sample of the study. Participants included in the study will be administered the Informed Consent Form, the "Demographic Information Form" created by the researcher, the "Fathers' Participation in Birth Scale", VAS scoring, "Birth Care Guide", "Observation Form Regarding Labor" and the "Birth Satisfaction Scale". Data will be analyzed using appropriate statistical methods. It is expected that the results obtained will contribute to the use of non-pharmacological methods in the birthing process and the support of partner participation.

Read the detailed description

This study investigates the effect of the rebozo technique, applied with partner support, on labor pain and satisfaction in primiparous pregnant women. It is a planned study involving a total of 64 participants. The data will be recorded three times after the pregnant woman reaches 5 centimeters of active labor in the first stage. There are two separate groups: a control group and an experimental group. Three follow-up observations will be conducted in both groups using the defined procedures, and the data will be recorded.

02

Conditions studied

  • Labor Pains

Browse trials for

Keywords

  • Rebozo Technique
  • Primiparous Pregnant
  • Spousal Support
  • Labor
  • Birth Satisfaction
03

In context

Labor Pain

423 studies on the registry are indexed under Labor Pain; 74 are open to participants now.

This study's planned enrollment of 64 is below the median of 100 across 347 interventional studies indexed under Labor Pain.

Browse Labor Pain studies →

Lead sponsor

Istanbul Saglik Bilimleri University is the lead sponsor of 60 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Those aged between 18 and 49,
  • Between 37-42 weeks of gestation,
  • Primiparous pregnancy,
  • In head presentation, the fetus is singular,
  • Those who have not been diagnosed with a high-risk pregnancy,
  • Someone who understands and can speak Turkish,
  • In the active phase (5cm and above),
  • The spouse is allowed to be present at the birth.

Exclusion criteria

Exclusion Criteria:

  • Those who experienced adjustment problems in the study,
  • Patients who require an emergency cesarean section,
  • Pregnancy with a known high-risk diagnosis (IUGR, fetal anomaly, polyhydramnios or oligohydramnios, presentation anomaly, multiple pregnancy, preeclampsia, etc.)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • No intervention
    Control Group

    In primiparous pregnant women in the active phase, routine midwifery care will be applied, and VAS scoring will be performed according to the stages of cervical effacement and dilation (3 times: 5cm, 6-8cm, 9-10cm).

  • Experimental
    Experimental Group

    The labor process will be recorded in the "Birth Care Guide" by the attending midwife, and routine midwifery care and rebozo technique will be applied. When dilation reaches 5 cm, a VAS I assessment will be performed on the pregnant woman before applying the rebozo technique, and cervical effacement, dilation, FHR, vital signs, head level, number and duration of contractions will be recorded in the "Birth Care Guide". Rebozo will be applied for 10 minutes between contractions using the technique chosen by the pregnant woman. 30 minutes after rebozo application, a VAS II assessment will be performed, and cervical effacement, dilation, FHR, vital signs, head level, number and duration of contractions will be recorded in the "Birth Care Guide". The same procedure will be applied when dilation reaches 6-8 cm and 9-10 cm.

    Other: Rebozo Technique

Interventions

  • OtherRebozo Technique

    Rebozo technique is a traditional Mexican practice that involves relaxation, rhythmic rocking, pelvic mobilization, and position changes during pregnancy and childbirth. Theses and research examining the effects of this technique on labor indicate that the rebozo method can contribute to shortening labor time and allow the mother to be more active during delivery. In our study, unlike other rebozo techniques, the aim is to provide "partner support." The rebozo technique will be applied with partner support during the three active phases of cervical effacement and dilation (5cm, 6-8cm, and 9-10cm), and the results will be recorded.

06

What researchers measure

Primary outcomes

  1. Labor Pains

    The VAS pain score is used to assess labor pain, and pain intensity is rated on a scale of 0 to 10. 0 indicates no pain, while 10 indicates unbearable pain.

    Time frame: The VAS pain assessment scale is a measurement used to evaluate labor from the active phase (5 cm) to the completion of the first stage (10 cm). The VAS pain score will be used from the beginning of active labor (5 cm) until the moment of birth (10 cm).

  2. Birth Satisfaction

    The Birth Satisfaction Scale is used to assess birth satisfaction. This scale is a measurement tool administered to women who have had vaginal deliveries during the postpartum period. It consists of three sub-dimensions and a total of 10 items. The scale is a 5-point Likert-type scale, with options ranging from 0 (strongly disagree), 1 (disagree), 2 (neutral), 3 (agree), and 4 (strongly agree).

    Time frame: The birth satisfaction scale is an assessment scale administered to women who have completed childbirth, within the first 24 hours after delivery.

07

Study locations

1 of 1 sites recruiting
  • Çerkezköy State Hospital
    Tekirdağ, 59000, Turkey (Türkiye)
    Recruiting
    • Beyza Halaç Bozkurt · Contactbyz.halac@gmail.com · +905074407167
    • Beyza Halaç Bozkurt · Principal investigator
    • Neriman Çağlayan Keleş, PhD Lecturer · Principal investigator
08

References and documents

Publications

  • Iversen ML, Midtgaard J, Ekelin M, Hegaard HK. Danish women's experiences of the rebozo technique during labour: A qualitative explorative study. Sex Reprod Healthc. 2017 Mar;11:79-85. doi: 10.1016/j.srhc.2016.10.005. Epub 2016 Oct 31. PubMed 28159133 ↗

Individual participant data

Plan to share: No — The "Voluntary Consent Form," which must be obtained from each pregnant woman at the beginning of the study, states that the researcher's personal information will be kept confidential, that it can only be reviewed by official authorities when necessary, and that only the results of the study may be published in the literature.

09

Updates

1 registry update since Sep 25, 2026
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date and date precision
1 update, last Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Minor edits only
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07752693
Lead sponsor
Istanbul Saglik Bilimleri University
Responsible party
Beyza Halaç Bozkurt (MIDWIFE, Istanbul Saglik Bilimleri University) — Principal investigator
First posted
Aug 7, 2026
Start date
May 1, 2026
Primary completion
Sep 30, 2026
Completion
Dec 31, 2026 (estimated)
Last update
Nov 5, 2026

Study contacts

Beyza Halaç Bozkurt
Contact
byz.halac@gmail.com
+905074407167

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion